Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.tem.2015.11.006 | DOI Listing |
Publication Analysis
Top Keywords
erratum 'tyrosine
4
'tyrosine kinase
4
kinase inhibitors
4
inhibitors diabetes
4
diabetes novel
4
novel treatment
4
treatment paradigm?'
4
paradigm?' [trends
4
[trends endocrinology
4
endocrinology metabolism
4
Similar Publications
Correction: Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes.
Naunyn Schmiedebergs Arch Pharmacol
December 2024
Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany.
Correction: EGFR inhibits TNF-α-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401.
Cell Death Differ
December 2024
Department of Biochemistry, College of Life Science and Technology, Institute for Bio-medical Convergence Science and Technology, Yonsei University, Seoul, Republic of Korea.
ERRATUM: The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
Endocr Relat Cancer
November 2024
School of Medicine and Medical Science, UCD Conway Institute, St Vincent's University Hospital and University College Dublin, Dublin, Ireland.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!